The effects of serotonin (5-HT), a well-known immunomodulator and neurotransmitter, on the ionic permeability of a pre-B lymphocyte cell line was investigated with the whole-cell patch-clamp technique. We found that physiological doses of this biogenic amine regulate a voltage-gated potassium channel by activating different subsets of receptors. More specifically, 5-HT induces in the recorded cells (a) increase in the maximum potassium conductance, which is due to activation of 5-HT,-like receptors, and (ii) acceleration of the inactivation process that is under the control of 5-HT3 receptors and, accordingly, is mimicked by the 5-UT3 agonist, 2-methyl-5-HT; involvement of those two distinct categories of receptors was demonstrated by using specific antagonists that block predominantly one or the other of these two actions. These two results show that hormones can affect lymphocyte physiology through modulation of their ionic conductances in a way that might help explain some of the diverse effects of 5-HT on neuronal cells.
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Lymphocytes have receptors for a variety of hormones (for review, see ref. 1 ). Serotonin, a major neurotransmitter (see, for example, refs. 2-4), has also been reported to modulate various aspects of the immune response (5) (6) (7) (8) (9) (10) , although the specific molecular targets that mediate these effects are unidentified. In the nervous system, this transmitter operates, at least in part, by modulating potassium conductances (2, (11) (12) (13) . Because a voltage-gated potassium channel is present in B lymphocytes (14) , as in other cells ofthe immune system (15, 16) , we investigated whether serotonin also modulates these channels in a pre-B cell line, found such to be the case, and further found that this amine acts on the activation and inactivation processes through distinct categories of receptors. This finding indicates common features for the effects of transmitters on the central nervous system and on the immune system.
METHODS Electrophysiological Recordings. Patch-clamp experiments
were done on the Abelson murine leukemia virus-infected 18-81 pre-B cell line (for details see ref. 14) . Just before recording (at room temperature 22-240C), the cells were washed of culture medium and bathed in 150 mM NaCl/4 mM KCl/1 mM MgCl2/1 mM CaCl2/10 mM Hepes buffer, pH 7.2.
The pipette solution was 140 mM KCl/4 mM NaCl/4 mM MgCl2/0.55 mM CaCl2/1.1 mM EGTA, pCa 7, 5 mM creatine phosphate/2.5 mM ATP/0.2 mM GTP/10 mM Hepes buffer, pH 7.2. Compounds for these, and for serotonin 5-hydroxytryptamine (5-HT) (creatine sulfate complex) solutions were from Sigma. Stocks of 20 mM 5-HT were dissolved in Ringer's solution at the desired concentration just before use and applied through a slow perfusion system placed near the recorded cell (1-2 ml/min; dead volume, 400 IA).
Current Parameter Measurements. The decaying part ofthe current is well-fitted by a single exponential function, and this property allows a simple estimate of the inactivation rates. In contrast, the activation kinetics display a more complex behavior [such is also the case in T cells (17) ] and was thus not extensively studied here because in first approximation it changed in parallel with inactivation upon different regulatory stimuli, such as increase ofinternal Ca2', cAMP (14) , or 5-HT. Because leakage currents are small in these cells (input resistance, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Gfk), the amplitude of the potassium current could be measured in this study between base line and peak current. Potassium currents were generally elicited by depolarizing voltage steps of 80 mV (jumping from a holding potential of -80 mV) in order to (i) avoid contamination by unspecific leakage currents (for which the electrical driving force is null at 0 mV) and (ii) because the K+ conductance and inactivation rates are close to maximum at this null potential (see also Fig. 1 B and C). Conductances were calculated from traces corrected for leakage (14) . Statistical data are expressed as the mean + SD of n experiments.
Pharmacological Study. Cells were incubated 10-15 min in Ringer's solution plus the antagonist studied before sealing; 5-HT with the same antagonist were then perfused no less than 6-10 min after entering whole-cell configuration to allow stabilization of recording conditions. Drugs were originally provided by the following sources: ketanserin (Janssen Pharmaceutica, Beerse, Belgium), laH,3a, 5aH-tropan-3-yl-3,5-dichlorobenzoate methanesulfonate (MDL72222) (MerrelDow, Strasbourg, France), methiotepin (Hoffman-La Roche, Basel), and metergoline (Farmitalia, Milan). 3a-Trophanyl-1H-indole-3-carboxylic acid ester (ICS-205-930) was a gift of Sandoz Pharmaceutical (Basel).
RESULTS
In pre-B and stimulated B cells, the major ionic conductance is a potassium channel activated at membrane potentials above -40 mV, which inactivates upon prolonged depolarizations (14) . Its basic features are illustrated in Fig. L4i , and in this study, two parameters of this current were analyzedi.e., its amplitude and the time constant, r, of the inactivation process (or inverse of inactivation rate) (see Methods). In the first 5-10 min after achieving whole-cell configuration, modifications occur in kinetics, amplitude, and voltage dependency (ref. 14 , see also refs. 17 and 18); care was therefore taken to evaluate the influence of 5-HT in stable conditions, which were reached in about 5-10 min after achieving whole-cell conformation.
5-HT Acts Both on Amplitude and Inactivation of the K+ Current. Fig. 1 induced in 2-3 min two different effects-a transient increase of the peak current elicited by depolarizing pulses and an increase in the rate at which it inactivated (trace 2 versus trace 1 in Fig. 1AJ ). During the subsequent 13 min of perfusion with 5-HT, amplitude of the current continuously decreased, whereas the inactivation rate kept decaying (trace 3 in Fig.  1AJ ). This sequence of events and a transient rebound in amplitude upon removal of 5-HT, associated with a small further increase in the inactivation rate, are shown in Fig. L42 . Note that inactivation rate did not recover, despite prolonged wash out of 5-HT.
5-HT affects potassium conductance and channel inactivation over the whole range of membrane potentials tested ( Fig.  1 B and C) . The plots in Fig. 1B , obtained just before and after addition of the transmitter, illustrate the increase in peak conductance and also a 7-mV shift towards negative potentials of the potential for half activation. This displacement of voltage dependency of the current activation was often more pronounced after prolonged perfusion. Fig. 1C shows the changes of voltage dependency in both the steady-state inactivation (Left) and the inactivation time constant (Right). The displacement of each curve to the left-i.e., to more negative potentials, reflects an overall decrease in percentage of activable potassium channels at a given holding potential. Note also a 135-ms reduction of the minimum inactivation time constant with strong depolarizations of the recorded cell with 5-HT.
It was not possible to differentiate the two effects of 5-HT (i.e., on amplitude and on inactivation of the K + currents) on concentration alone. Two to five ,uM (five cells) and 10-20 ,uM of 5-HT induced qualitatively similar effects, whereas lower doses were either ineffective (100 nM, four cells; 500 nM, one cell), or produced very slow and small variations ofthe current (500 nM, six cells). Results obtained with 10-20 ,uM of 5-HT are summarized in Fig. 2 . In addition, the effects of 5-HT on the two components of the currents were somewhat dissociated in time, that on its amplitude being only transient and the most rapid. In 32 cells, serotonin increased the current by +40% + 23% in 1-2 min, and the increase was still 17% + 22% after 5 min of perfusion with the drug. In 15 of these cells in which the inactivation time constant was studied in detail, T was only decreased by -3% 14% after 1 min, but by -27% + 19% after 5 min of perfusion. Removal of 5-HT from the perfusing bath was followed by two noticeable features. (i) Generally, the current did not return to control values, although again its amplitude and decay time constant did not necessarily exhibit parallel behavior. In 10 cells of 32 we observed a transient rebound of the current amplitude (Fig. 1A2) 
F'1r* , control experiments with no antagonist. Bars represent SDs; n is in parentheses. Statistical significance (with respect to control) was assessed using a paired Student's t test. *, P < 0.05, **, P < 0.01. second effect of 5-HT was not due to the elapsed time after achieving whole-cell configuration because in five cells where 5-HT was applied as long as 13-20 min after seal establishment, we saw the typical responses.
5-HT Effects Can Be Pharmacologically Dissected. The nature of the 5-HT receptors involved in such effects was studied using classical and recently described specific receptor antagonists (for review, see ref. 19) . A composite effect due to involvement of more than one receptor was also investigated. Fig. 3 Al-A2 demonstrates the role of 5-HT3 receptors in the regulation of the inactivation process: in the presence of ICS-205-930, a specific antagonist of this class (20) , application of 10 uM 5-HT induced an increase in current amplitude, but the increase in rate of inactivation was either absent or small and delayed. In this cell, 6 min after wash-out of all drugs, perfusion of 5-HT alone produced an increase in both current amplitude and inactivation. Another 5-HT3 antagonist, MDL72222, had qualitatively the same ability to block the 5-HT-induced increased inactivation rate but did so in a manner difficult to interpret: preincubation (see Methods) with 50 MuM MDL72222 by itself already caused a marked increase in the rate of current inactivation (30-40%) as compared with control currents. In addition, upon perfusion of these cells with 5-HT plus MDL72222, we consistently saw an immediate and transient (2-3 min) decrease of the inactivation rate associated with an increase in current amplitude. After 5 min of such a perfusion, was back to control value, and as in Fig. 3A2 , current amplitude remained stable. The involvement of 5-HT3 receptors in the control of the inactivation process was further established by using 2-methyl-5-HT, a specific agonist of this receptor subtype (20) ; in nine cells perfusion with this drug at 30 ,4M
induced an irreversible increase in the rate of inactivation (37 ± 13%), with only a small (9 ± 5%) and transient increase in current amplitude. This compound had no effect in presence of 10 ,uM ICS-205-930 (n = 2; data not shown).
One experiment indicating a role of 5-HT1 receptors is illustrated in Fig. 3 B1 and B2 . Methiotepine, a blocker of both 5-HT1 and 5-HT2 receptors was used; in its presence the current amplitude was not increased by 5-HT, but rather a 17% reduction was seen. On the other hand, the rate of inactivation was speeded, a finding in agreement with the idea that inactivation is controlled by a particular set of receptors. Another 5-HT1 and 5-HT2 blocker, metergoline, at 1 uM, yielded essentially similar results to methiotepine, whereas methysergide (Sandoz), a more specific antagonist of 5-HT2 receptors (19, 21) , was ineffective at doses up to 30 MLM (data not shown). That 5-HT2 receptors are not involved in the control ofthe K+ current, was further confirmed by the fact that ketanserin, a specific antagonist at this class, had no major effect at doses up to 10 ,uM. It was not possible to determine more accurately which subtype of 5-HT1 receptor is involved because selective compounds are not yet available for this purpose. However, 8-hydroxy-2-(di-npropylamino)tetralin (8-OH-DPAT), a 5-HTlA ligand, had no agonist action at concentrations up to 10MuM (n = 5). Finally, neither amplitude nor inactivation rate were affected by 5-HT when both the 5-HT3 blocker ICS-205-930 (10 MM) and the 5-HT1/2 blocker metergoline (1 MuM) were used simultaneously (data not shown). Pharmacological results of this study are summarized in Fig. 2 .
Because some of the antagonists used may also display agonistic properties (19), we tested their direct action and found that all of them induced, to some extent, a fully and rapidly reversible increase in the rate of inactivation of the potassium current (data not shown). Except for MDL72222 (see above), this effect required doses higher than those necessary to obtain full blockade of the 5-HT-mediated response.
DISCUSSION
The potassium channel expressed in pre-B and stimulated B cells closely resembles the type n channel described in T cells (15, 22, 23) : both inactivate almost fully upon prolonged depolarization, are blocked by 20 mM tetraethylammonium or 10 mM Co2 + (14) , and display use-dependent inactivation. The presence of a small number of other K+ channel types cannot be excluded, but several indications suggest that the target for the 5-HT effects is only this type n K+ channel; the inactivation kinetics are well fitted by a single exponential function, and steady-state inactivation is always more pronounced after 5-HT action-thus eliminating the possibility that a noninactivating component of the type n' or 1 is unmasked (22, 23) .
Our results demonstrate that physiological doses of 5-HT (24) modulate the potassium current of lymphocytes through at least two different receptors. The increase of peak conductance and the acceleration of inactivation are likely to be mediated by 5-HT1 and 5-HT3 receptors, respectively. The 5-HT2 receptor does not seem to be involved.
The decrease in current amplitude seen upon prolonged perfusion of 5-HT alone, with or without 5-HT112 antagonists can be accounted for by the fact that when 5-HT is present, substantially fewer channels become available for activation at the holding potential (see Fig. 1C ). This hypothesis is further supported by the lack oflong-term decrease in current amplitude in the presence of 5-HT3 antagonists (Fig. 2) . Our inability to repeat the action of 5-HT on the same cell as well as the fact that even prolonged wash-out did not restore the current-inactivation rate to its control value may be due either to 5-HT-induced irreversible changes along the transduction chain, such as, for example, a phosphorylation of the receptors and/or channels (25) or to the translocation toward the cytosol of an essential membrane-bound transducing protein, which is then secondarily lost by diffusion into the recording pipette.
Our results must be compared with those obtained in neurons, where the role of 5-HT has been best analyzed at the channel level (2, (11) (12) (13) and in the immune system itself. In vertebrate, as well as in invertebrate neurons, 5-HT can generate in the same cell composite excitatory/inhibitory actions (2, 26) . In some cases the origin of these complex responses have been somewhat elucidated; particularly, in hippocampal neurons, where it has recently been shown that several potassium conductances are opened or closed by activation of different subsets of receptors (12, 13) . Our results, however, indicate that this transmitter can act through different receptors but on the same conductance, and the same dualism might appear in some neurons when each conductance is analyzed in detail. Furthermore, 5-HT receptors are coupled to activation of different second-messenger pathways in the nervous system (4) as well as in lymphocytes, where augmentation of intracellular cGMP seems to account solely for the 5-HT-induced increase of current amplitude (unpublished observation), and where Ca2" and cAMP also close the potassium conductance studied here (14) .
Potassium channels are thought to play an important role in the physiology of lymphocytes. These channels are required for a variety of effector functions, including mitogenesis, secretion of lymphokines (27) , cytolysis of target cells by natural killer cells (28) and volume regulation (29) , and their expression follows T-cell differentiation (23) . On the other hand, recent data indicate that 5-HT acts directly through various receptors on the cellular components of the immune system: this biogenic amine increases chemotactic activity of human lymphocytes (30) , suppresses mitogeninduced proliferation of murine lymphocytes (31), modulates interferon y-induced macrophage phagocytosis (10) , and increases the cytotoxicity of natural killer cells (9) . It is therefore attractive to suggest that, as in neurons, 5-HT acts on the immune cells by, at least in part, regulating ionic permeabilities.
